// App-Quantinova.ai

1403 : Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Kimberly Komatsubara

Principal Investigators

  • Tamara J. Dunn

  • Daniel J Lee

  • Steven Coutre

  • Caroline Berube

  • Jason R. Gotlib

  • Bruno C. Medeiros

  • Michaela Liedtke

Medical Centers

  • Stanford School of Medicine, Stanford, CA

  • Department of Pathology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA

  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

  • Human albumin

  • White Blood Cell

Drug/Treatment

  • PEG-asparaginase

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Asparaginase

  • Prednisone

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved